An app that nudged long COVID patients to pace themselves did not reduce crashes

Pacing — planning activity against a limited daily energy budget so as to avoid the delayed symptom crashes known as post-exertional malaise — is the closest thing long COVID has to a standard self-management strategy. It is also, in principle, an obvious fit for a wearable tracker: the device knows how much you have moved, so it could tell you when to stop. A randomised trial published in Nature Communications tested that idea, and did not find the benefit.

The trial

The six-month pragmatic randomised controlled trial (ISRCTN16033549) compared a just-in-time intervention supporting energy management in adults with long COVID against standard care [s1]. Participants in the intervention arm received the "Pace Me" app together with a wearable activity tracker; the control arm received an app with data entry screens only [s1].

The intervention itself was the messaging. When participants reached 50%, 75% and 100% of their daily "activity allowance," the app sent just-in-time energy-management messages [s1]. This is a reasonable operationalisation of what pacing coaching does in person, delivered continuously rather than at appointments.

Of 369 people assessed for eligibility, 250 were randomised 1:1, and the final per-protocol analysis included 77 controls and 84 intervention participants [s1]. The gap between 250 randomised and 161 analysed is large and is itself a finding about how hard this population is to keep in a six-month digital trial.

The primary outcome was post-exertional malaise, measured with the DePaul Symptom Questionnaire-PEM (DSQ-PEM) [s1].

The result

There was no time-by-group interaction on the DSQ-PEM [s1]. In the intervention group, scores moved from 48 (95% CI 44–53) at baseline to 46 (95% CI 41–51) after the intervention; in the control group, from 47 (95% CI 42–52) to 44 (95% CI 39–49) [s1]. The interaction effect had a p value of 0.614 and a partial eta squared of 0.002, which the authors characterise as trivial [s1]. No individual question on the questionnaire showed an interaction effect either (all p > 0.05) [s1].

Two things are worth separating here. Both groups improved slightly. The intervention did not improve them more than the control did.

Why the authors think it may have come out this way

The paper does not treat the null as the end of the question. The authors note that long COVID has substantial reported recovery rates, and that their wide inclusion criteria may therefore have masked intervention effects — if a meaningful share of participants were improving on their own trajectory, a pacing intervention has less room to show a difference [s1]. On that reasoning, they suggest the energy-management framework should be tested in conditions without such recovery rates, naming chronic fatigue syndrome specifically [s1].

That is a plausible reading, and it is also the kind of post-hoc explanation that needs its own test before it counts as evidence. The trial as designed answers a narrower question than "does pacing work": it answers whether adding automated activity-threshold messaging to a tracker changes post-exertional malaise over six months in a broadly recruited long COVID population. The answer to that question was no.

The control condition also deserves attention. Control participants received an app with data-entry screens, meaning they were self-monitoring too [s1]. Self-monitoring is not an inert placebo in a condition where the therapeutic skill is noticing your own limits.

The comparison case

Four days later, a small pilot in Medicina reported on pacing delivered the traditional way — as a structured programme with sessions — in Portugal, where the authors note ME/CFS is not well recognised and no feasibility evidence for pacing existed [s2].

The pilot ran an eight-week programme in patients with an official ME/CFS diagnosis, focusing on recruitment feasibility, protocol adherence and acceptability, with exploratory pre-post comparison of Chalder fatigue questionnaire and SF-36 physical functioning scores [s2]. Thirteen patients were recruited; they attended an average of seven of the eight expected sessions, and seven (53.8%) adhered to the protocol [s2]. Among the ten who answered a post-intervention survey, respondents considered the intervention addressed the specific needs of people living with ME/CFS [s2]. Average fatigue score fell from 27.5 to 17.7 and mean physical functioning rose from 24.6 to 31.7 [s2].

Those numbers look impressive and mean very little on their own, which the authors say plainly: the study was exploratory, had no control group, and its stated conclusion is that larger benchmark studies with longer interventions and a control arm are feasible and needed, so that placebo effects can be accounted for [s2].

What this pair actually shows

Placed side by side, the two papers describe the current state of pacing evidence with unusual clarity. The properly controlled trial of an automated, scalable version found no effect on its primary outcome [s1]. The uncontrolled pilot of the labour-intensive, human-delivered version produced large-looking before-and-after changes that no design element can distinguish from regression to the mean, natural fluctuation or expectation [s2].

Neither result says pacing does not help people. Both say the evidence base is not yet capable of showing whether it does, and that the digital shortcut — thresholds plus notifications — did not substitute for whatever the in-person version consists of.

What to watch

The Nature Communications authors' own suggestion is the obvious next step: test the same energy-management framework in ME/CFS, where spontaneous recovery is rarer [s1]. The Portuguese group is proposing a controlled trial in the same disease [s2]. If both happen, the question of whether app-delivered pacing does anything may finally be answerable.

Sources

• [s1] A digital platform with activity tracking for energy management support in long COVID: a randomised controlled trial. Nature Communications, 2 February 2026. https://doi.org/10.1038/s41467-025-64831-y
• [s2] A short-term pacing intervention in people with myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study in Portugal. Medicina, 6 February 2026. https://doi.org/10.3390/medicina62020331